Biogen Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good morning from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Biogen, and CEO Michel Vounatsos.
Please note that following this presentation, we will have a Q&A session right here in this Zoom room where you'll also be able to submit your questions via the little blue Ask A Question button in your conference portal. So with that, Michel, thanks for being here today, and let me turn things over to you.
Thank you, Cory. Good day, everyone, and thank you for joining the Biogen session. I would like to point out that we'll be making some forward-looking statements, which are based on our expectation and beliefs. These statements are subject to risks and uncertainties. So therefore, I encourage you to consult the risk factors discussed in our SEC filing.
I would like to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
